Zacks Investment Research
19 Oct 2026, 22:51 UTC · 58m ago
Medtronic (MDT) Stock Dips While Market Gains: Key Facts
Impact · against what's priced in
The article provides no new fundamental catalysts for Medtronic, as the projected earnings decline and revenue growth are already baked into the current valuation. The recent 2.09% price dip is a technical move that does not alter the core assumptions regarding the company's organic growth or robotics upside.
- MDT+0.00
Already priced in
- The price assumes
Fiscal 2027 organic revenue growth of 7.25%–7.75% and non-GAAP EPS of $5.94–$6.00
The analysts' consensus for full-year revenue of $38.97 billion (up 7.16%) and EPS of $5.98 aligns exactly with the growth figures the market is already paying for.
What MDT's price assumes · Sep 9
Top 2 movers · tap to explore
